Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft
β Scribed by F. R. Luo; Z. Yang; H. Dong; A. Camuso; K. McGlinchey; K. Fager; C. Flefleh; D. Kan; I. Inigo; S. Castaneda; W. C. Rose; R. A. Kramer; R. Wild; F. Y. Lee
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 358 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A pharmacodynamic analysis of cis-diamminedichloroplatinum(I1) (DDP) was conducted using two human gastric cancer xenografts, SC-1-NU and MKN-45, and one human breast cancer xenograft, MX-1, grown serially in BALB/c nu/nu mice. DDP was administered intrapentoneally (ip) at a total dose of 5, 10, or
The distribution of the novel anticancer drug candidate Brequinar Sodium (DuP 785, NSC 368390) was studied in control mice and mice implanted subcutaneously with human colon carcinoma xenografts. Mice were given radiolabeled 14C-Brequinar Sodium intravenously. Brequinar concentrations in blood and v
In a model of nude mice bearing a human colon carcinoma xenograft, the biodistribution and tumor localization of metatetrahydroxyphenylchlorin (m-THPC) coupled to polyethylene glycol (PEG) were compared with those of the free form of this photosensitizer used in photodynamic therapy (PDT). At differ
## Abstract We have previously described the development and testing of a monoclonal antiβhuman CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur